News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
McAvoy David R.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/04/2023 |
4
| McAvoy David R. (Gen Counsel, CCO, & Secretary) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 7,358 shares
@ $0.9798, valued at
$7.2k
Exercised 20,000 restricted stock units
@ $0 |
|
01/26/2023 |
4
| McAvoy David R. (Gen Counsel, CCO, & Secretary) has filed a Form 4 on Fresh Tracks Therapeutics, Inc.
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/21/2020 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.
Txns:
| Bought 16,526 shares
@ $0.8298, valued at
$13.7k
Bought 6,000 shares
@ $0.8398, valued at
$5k
|
|
09/17/2020 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.
Txns:
| Granted 350,000 options to buy
@ $0.8, valued at
$280k
|
|
06/22/2020 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.
Txns:
| Bought 30,435 shares
@ $0 Bought 30,435 warrants
@ $1.25, valued at
$38k
|
|
03/18/2020 |
4
| McAvoy David R. (General Counsel and CCO) has filed a Form 4 on Brickell Biotech, Inc.
Txns:
| Granted 25,000 restricted stock units
@ $1.54, valued at
$38.5k
|
|
12/21/2018 |
4
| McAvoy David R. (General Counsel) has filed a Form 4 on ENDOCYTE INC
Txns:
| Disposed/sold 2,119 shares
@ $24, valued at
$50.9k
Disposed/sold 23,750 shares
@ $24, valued at
$570k
Disposed/sold 37,500 options to buy
@ $2.96, valued at
$111k
|
|
|
|